RGD-conjugated human ferritin nanoparticles for imaging vascular inflammation and angiogenesis in experimental carotid and aortic disease

Molecular Imaging and Biology

Volumn 14, Issue 3, 2012, Pages 315-324

  Kitagawa, Toshiro ^a   Kosuge, Hisanori ^a   Uchida, Masaki ^b   Dua, Monica M ^a   Iida, Yasunori ^a   Dalman, Ronald L ^a   Douglas, Trevor ^b   McConnell, Michael V ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MONTANA STATE UNIVERSITY   (United States)

Author keywords

Aneurysms; Angiogenesis; Atherosclerosis; Ferritin; Inflammation; Nanoparticles; RGD; Vascular disease

Indexed keywords

ARGINYLGLYCYLASPARTIC ACID FERRITIN CONJUGATE; CONTRAST MEDIUM; NANOPARTICLE; UNCLASSIFIED DRUG;

ABDOMINAL AORTA ANEURYSM; ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAROTID ARTERY DISEASE; CONTROLLED STUDY; DIABETES MELLITUS; DRUG BINDING; ENDOTHELIUM CELL; EX VIVO STUDY; FLUORESCENCE IMAGING; HISTOPATHOLOGY; HYPERLIPIDEMIA; IN VIVO STUDY; MACROPHAGE; MOLECULAR IMAGING; MOLECULAR PATHOLOGY; MOUSE; NEAR INFRARED FLUORESCENCE IMAGING; NONHUMAN; PRIORITY JOURNAL; VASCULITIS;

ANIMALS; AORTIC DISEASES; CAROTID ARTERIES; CAROTID ARTERY DISEASES; CATTLE; CELLS, CULTURED; DIAGNOSTIC TECHNIQUES, CARDIOVASCULAR; DISEASE MODELS, ANIMAL; ENDOTHELIAL CELLS; FERRITINS; HUMANS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MACROPHAGES; MALE; MICE; MICE, TRANSGENIC; NANOPARTICLES; NEOVASCULARIZATION, PATHOLOGIC; OLIGOPEPTIDES; PROTEIN BINDING; SPECTROMETRY, FLUORESCENCE; SPECTROSCOPY, NEAR-INFRARED; TOMOGRAPHY;

MUS;

EID: 84861481588     PISSN: 15361632     EISSN: 18602002     Source Type: Journal    
DOI: 10.1007/s11307-011-0495-1     Document Type: Article

References (35)

1. Libby P (2002) Inflammation in atherosclerosis. Nature 420:868-874
2. Galis ZS, Sukhova GK, Lark MW, Libby P (1994) Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest 94:2493-2503 (Pubitemid 24379627)
3. Sukhova GK, Shi GP, Simon DI, Chapman HA, Libby P (1998) Expression of the elastolytic cathepsins S and K in human atheroma and regulation of their production in smooth muscle cells. J Clin Invest 102:576-583 (Pubitemid 28376160)
4. Shimizu K, Mitchell RN, Libby P (2006) Inflammation and cellular immune response in abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol 26:987-994 (Pubitemid 43732102)
5. Lindholt JS, Vammen S, Fasting H, Henneberg EW, Heickendorff L (2000) The plasma level of matrix metalloproteinase 9 may predict the natural history of small abdominal aortic aneurysms. A preliminary study. Eur J Vasc Endovasc Surg 20:281-285
6. Virmani R, Kolodgie FD, Burke AP et al (2005) Atherosclerotic plaque progression and vulnerability to rupture: angiogenesis as a source of intraplaque hemorrhage. Arterioscler Thromb Vasc Biol 25:2054-2061 (Pubitemid 41416300)
7. Tedesco MM, Terashima M, Blankenberg FG et al (2009) Analysis of in situ and ex vivo vascular endothelial growth factor receptor expression during experimental aortic aneurysm progression. Arterioscler Thromb Vasc Biol 29:1452-1457
8. Saraff K, Babamusta F, Cassis LA, Daugherty A (2003) Aortic dissection precedes formation of aneurysms and atherosclerosis in angiotensin II-infused. Apolipoprotein E deficient mice. Arterioscler Thromb Vasc Biol 23:1621-1426
9. Paik DC, Fu C, Bhattacharya J, Tilson MD (2004) Ongoing angiogenesis in blood vessels of the abdominal aortic aneurysm. Exper Mol Med 36:524-533 (Pubitemid 40129174)
10. Choke E, Thompso MM, Dawson J et al (2006) Abdominal aortic aneurysm rupture is associated with increased medial neovascularization and overexpression of proangiogenic cytokines. Arterioscler Thromb Vasc Biol 26:2077-2082 (Pubitemid 44253791)
11. Hoshiga M, Alpers CE, Smith LL, Giachelli CM, Schwartz SM (1995) Alpha-v beta-3 integrin expression in normal and atherosclerotic artery. Circ Res 77:1129-1135
12. Antonov AS, Kolodgie FD, Munn DH, Gerrity RG (2004) Regulation of macrophage foam cell formation by alphaVbeta3 integrin: potential role in human atherosclerosis. Am J Pathol 165:247-258 (Pubitemid 38821832)
13. Waldeck J, Häger F, Höltke C et al (2008) Fluorescence reflectance imaging of macrophage-rich atherosclerotic plaques using an alphavbeta3 integrin-targeted fluorochrome. J Nucl Med 49:1845-1851
14. Laitinen I, Saraste A, Weidl E et al (2009) Evaluation of alphavbeta3 integrin-targeted positron emission tomography tracer 18F-galacto-RGD for imaging of vascular inflammation in atherosclerotic mice. Circ Cardiovasc Imaging 2:331-338
15. Winter PM, Morawski AM, Caruthers SD et al (2003) Molecular imaging of angiogenesis in early-stage atherosclerosis with alpha (v) beta3-integrin- targeted nanoparticles. Circulation 108:2270-2274 (Pubitemid 37363046)
16. Liepold L, Anderson S, Willits D et al (2007) Viral capsids as MRI contrast agents. Magn Reson Med 58:871-879 (Pubitemid 350074353)
17. Hooker JM, Datta A, Botta M, Raymond KN, Francis MB (2007) Magnetic resonance contrast agents from viral capsid shells: a comparison of exterior and interior cargo strategies. Nano Lett 7:2207-2210 (Pubitemid 47310107)
18. Anderson EA, Isaacman S, Peabody DS, Wang EY, Canary JW, Kirshenbaum K (2006) Viral nanoparticles donning a paramagnetic coat: conjugation of MRI contrast agents to the MS2 capsid. Nano Lett 6:1160-1164 (Pubitemid 44013476)
19. Uchida M, Terashima M, Cunningham CH et al (2008) A human ferritin iron oxide nano-composite magnetic resonance contrast agent. Magn Reson Med 60:1073-1081
20. Uchida M, Flenniken ML, Allen M et al (2006) Targeting of cancer cells with ferrimagnetic ferritin cage nanoparticles. J Am Chem Soc 128:16626-16633 (Pubitemid 46032741)
21. Aime S, Frullano L, Geninatti, Crich S (2002) Compartmentalization of a gadolinium complex in the apoferritin cavity: a route to obtain high relaxivity contrast agents for magnetic resonance imaging. Angew Chem Int Ed 41:1017-1019
22. Flenniken ML, Willits DA, Brumfield S, Young MJ, Douglas T (2003) The small heat shock protein cage from methanococcus jannaschii is a versatile nanoscale platform for genetic and chemical modification. Nano Lett 3:1573-1576 (Pubitemid 37518174)
23. Liepold LO, Abedin MJ, Buckhouse ED, Frank JA, Young MJ, Douglas T (2009) Supramolecular protein cage composite MR contrast agents with extremely efficient relaxivity properties. Nano Lett 9:4520-4526
24. Terashima M, Uchida M, Kosuge H et al (2011) Human ferritin cages for imaging vascular macrophages. Biomaterials 32:1430-1437
25. Uchida M, Willits DA, Muller K et al (2009) Intracellular distribution of macrophage targeting ferritin-iron oxide nanocomposite. Adv Mater 21:458-462
26. Arap W, Pasqualini R, Ruoslahti E (1998) Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model. Science 279:377-380 (Pubitemid 28063372)
27. Kułdo JM, Ogawara KI, Asgeirsdóttir SA et al (2005)Molecular pathways of endothelial cell activation for (targeted) pharmacological intervention of chronic inflammatory diseases. Curr Vasc Pharmacol 3:11-39 (Pubitemid 40089525)
28. Terashima M, Ehara S, Yang E et al (2010) In vivo bioluminescence imaging of inducible nitric oxide synthase gene expression in vascular inflammation. Mol Imaging Biol. doi:10.1007/s11307-010-0451-5
29. Kumar A, Lindner V (1997) Remodeling with neointima formation in the mouse carotid artery after cessation of blood flow. Arterioscler Thromb Vasc Biol 17:2238-2244 (Pubitemid 28057127)
30. Daugherty A, Manning MW, Cassis LA (2000) Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice. J Clin Invest 105:1605-1612 (Pubitemid 30390311)
31. Pang JH, Jiang MJ, Chen YL et al (1996) Increased ferritin gene expression in atherosclerotic lesions. J Clin Invest 97:2204-2212
32. Li W, Xu LH, Forssell C, Sullivan JL, Yuan XM (2008) Overexpression of transferrin receptor and ferritin related to clinical symptoms and destabilization of human carotid plaques. Exp Biol Med 233:818-826
33. Brooks PC, Clark RA, Cheresh DA (1994) Requirement of vascular integrin alpha v beta 3 for angiogenesis. Science 264:569-571
34. Ntziachristos V, Ripoll J, Wang LV, Weissleder R (2005) Looking and listening to light: the evolution of whole-body photonic imaging. Nat Biotechnol 23:313-320 (Pubitemid 41094419)
35. Nahrendorf M, Waterman P, Thurber G et al (2009) Hybrid in vivo FMT-CT imaging of protease activity in atherosclerosis with customized nanosensors. Arterioscler Thromb Vasc Biol 29:1444-1451